Inventor · disambiguated record
Vishal Verma
Also filed as: VERMA VISHAL · VERMA VISHAL A · VERMA VISHAL ANIL
23 granted patents·9 pending applications·189 citations·filing 2009–2025
93Inventor score
Top patents by PatentIndex Score
32 records- 0194US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 0294US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 0394US8697694B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2009·Granted Apr 15, 2014·52 cites·7 claims
- 0490US9408863B25′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 9, 2016·13 cites·12 claims
- 0587US9150603B22′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 6, 2015·14 cites·21 claims
- 0684US10179782B2Substituted sulfonamide compoundsGENENTECH INC·Filed 2016·Granted Jan 15, 2019·5 cites·10 claims
- 0783US10533058B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2014·Granted Jan 14, 2020·2 cites·7 claims
- 0881US10124069B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2016·Granted Nov 13, 2018·3 cites·26 claims
- 0976US9416154B25′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 16, 2016·4 cites·19 claims
- 1073US2025074881A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 1172US11236046B2Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulatorsGENENTECH INC·Filed 2019·Granted Feb 1, 2022·0 cites·1 claims
- 1269US11576979B2Pyrrolobenzodiazepine prodrugs and antibody conjugates thereofGENENTECH INC·Filed 2019·Granted Feb 14, 2023·0 cites·10 claims
- 1369US9999681B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2016·Granted Jun 19, 2018·1 cites·30 claims
- 1468US12110276B2Pyrazolo compounds and methods of use thereofGENENTECH INC·Filed 2022·Granted Oct 8, 2024·0 cites·28 claims
- 1567US12275745B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Granted Apr 15, 2025·0 cites·20 claims
- 1664US9433621B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2011·Granted Sep 6, 2016·1 cites·7 claims
- 1763US11692043B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2019·Granted Jul 4, 2023·0 cites·6 claims
- 1859US2018282272A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1958US10632210B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2018·Granted Apr 28, 2020·0 cites·7 claims
- 2058US2025171464A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 2157US2024425478A1Cyclopentylpyrazole cdk2 inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2257US2018118680A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2017·Application pending·0 cites
- 2357US2024183860A1Chimeric ABC Transporters and Screening MethodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 2453US2016221945A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2552US10532108B2Pyrrolobenzodiazepine prodrugs and antibody conjugates thereofGENENTECH INC·Filed 2019·Granted Jan 14, 2020·0 cites·29 claims
- 2651US10766878B2Sulfonylcycloalkyl carboxamide compoundsGENENTECH INC·Filed 2019·Granted Sep 8, 2020·0 cites·23 claims
- 2750US10695348B2Sulfonyl pyridyl TRP inhibitorsGENENTECH INC·Filed 2019·Granted Jun 30, 2020·0 cites·10 claims
- 2847US10597383B2Bicyclic proline compoundsGENENTECH INC·Filed 2019·Granted Mar 24, 2020·0 cites·19 claims
- 2945US2018021450A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3044US10442836B21-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatmentGENENTECH INC·Filed 2014·Granted Oct 15, 2019·0 cites·34 claims
- 3140US2018125995A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3237US10544215B21-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatmentGENENTECH INC·Filed 2016·Granted Jan 28, 2020·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Vishal Verma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →